RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Natus Medical - Stock

Natus Medical ROE 2024

Natus Medical ROE

0.03

Ticker

NTUS

ISIN

US6390501038

WKN

578916

In 2024, Natus Medical's return on equity (ROE) was 0.03, a 0% increase from the 0 ROE in the previous year.

Natus Medical Aktienanalyse

What does Natus Medical do?

Natus Medical Inc is a US-American medical technology company that operates in two main areas: neurology and neonatal care. The company was founded in 1989 under the name "Neometrics" and has since conducted numerous acquisitions, thus expanding into new areas. The business model of Natus Medical Inc is focused on providing state-of-the-art medical technologies that improve the diagnosis and treatment of patients. The company works closely with medical professionals, hospitals, and clinics to ensure the best possible patient care. The neurology division of Natus Medical Inc focuses on providing diagnostic tools for the diagnosis and monitoring of neurological disorders such as epilepsy, stroke, multiple sclerosis, and the like. Products include electroencephalography (EEG) and electromyography (EMG) devices, neurofeedback systems, and software for reporting. The neonatal care division of Natus Medical Inc offers a wide range of products for the care of premature and newborn infants. These include incubators, ventilators, monitoring devices, and phototherapy systems. Natus Medical Inc products are used in clinics and neonatology departments around the world and aim to improve the health and well-being of newborns. With the acquisition of Otometrics and Bio-logic Systems, Natus Medical Inc has expanded its product range to include audiology products. The audiology division offers a wide range of diagnostic tools for audiologists and ENT physicians, including comprehensive audiometric testing devices for children and adults, balance testing devices, and OAE screening systems. Natus Medical Inc places great emphasis on research and development and continuously invests in new technologies to provide even more effective diagnostic and treatment options for patients. The company is also dedicated to the education and training of healthcare personnel by offering trainings and continuing education for medical staff, as well as comprehensive technical support for the users of its products. Looking to the future, Natus Medical Inc plans further expansion, particularly on an international level. The company already has a strong presence in North America and now aims to expand in Europe and Asia. The company focuses on adapting its products and services to the different needs and requirements of each market. Overall, Natus Medical Inc is an innovative and future-oriented company that provides state-of-the-art medical technologies for the diagnosis and treatment of patients. With continuous investments in research and development, as well as its strong presence in the international market, the company is well positioned to continue growing and maintain its leading position in the medical technology industry. Natus Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Natus Medical's Return on Equity (ROE)

Natus Medical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Natus Medical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Natus Medical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Natus Medical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Natus Medical Stock

What is the ROE (Return on Equity) of Natus Medical this year?

The ROE of Natus Medical this year is 0.03 undefined.

How has the Return on Equity (ROE) of Natus Medical developed compared to the previous year?

The ROE of Natus Medical has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Natus Medical?

A high ROE indicates that Natus Medical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Natus Medical?

A low ROE can indicate that Natus Medical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Natus Medical affect the company?

A change in ROE (Return on Equity) of Natus Medical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Natus Medical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Natus Medical?

Some factors that can influence Natus Medical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Natus Medical pay?

Over the past 12 months, Natus Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Natus Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Natus Medical?

The current dividend yield of Natus Medical is .

When does Natus Medical pay dividends?

Natus Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Natus Medical?

Natus Medical paid dividends every year for the past 0 years.

What is the dividend of Natus Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Natus Medical located?

Natus Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Natus Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Natus Medical from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Natus Medical pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Natus Medical in the year 2023?

In the year 2023, Natus Medical distributed 0 USD as dividends.

In which currency does Natus Medical pay out the dividend?

The dividends of Natus Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Natus Medical

Our stock analysis for Natus Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Natus Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.